Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Mar2015, Vol. 3 Issue 3, p190-200, 11p
- Subject
HIV infections THERAPEUTICS TUBERCULOSIS vaccines IMMUNOGENETICS CLINICAL drug trials ANTIRETROVIRAL agents IMMUNE response RANDOMIZED controlled trials - Language
- ISSN
- 22132600